202 related articles for article (PubMed ID: 21716879)
1. Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.
Christudoss P; Selvakumar R; Fleming JJ; Gopalakrishnan G
Indian J Urol; 2011 Jan; 27(1):14-8. PubMed ID: 21716879
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
Khalighinejad P; Parrott D; Jordan VC; Chirayil S; Preihs C; Rofsky NM; Xi Y; Sherry AD
Invest Radiol; 2021 Jul; 56(7):450-457. PubMed ID: 34086013
[TBL] [Abstract][Full Text] [Related]
3. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
Ogunlewe JO; Osegbe DN
Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
[TBL] [Abstract][Full Text] [Related]
4. Zinc and cadmium analysis in human prostate neoplasms.
Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
[TBL] [Abstract][Full Text] [Related]
5. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
Feustel A; Wennrich R; Steiniger D; Klauss P
Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
[TBL] [Abstract][Full Text] [Related]
6. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
Feustel A; Wennrich R
Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
[TBL] [Abstract][Full Text] [Related]
7. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
8. TESTOSTERONE AND SERUM ZINC LEVELS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA.
Radhi G; Hilal N; Abdul-Aziz M
Georgian Med News; 2023; (340-341):81-86. PubMed ID: 37805879
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
[TBL] [Abstract][Full Text] [Related]
11. Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices.
Feustel A; Wennrich R
Urol Res; 1984; 12(5):253-6. PubMed ID: 6083653
[TBL] [Abstract][Full Text] [Related]
12. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
13. Biochemical profiles of prostatic fluid from normal and diseased prostate glands.
Grayhack JT; Lee C; Oliver L; Schaeffer AJ; Wendel EF
Prostate; 1980; 1(2):227-37. PubMed ID: 15619922
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of zinc levels in benign and malignant lesions of the prostate.
Goel T; Sankhwar SN
Scand J Urol Nephrol; 2006; 40(2):108-12. PubMed ID: 16608807
[TBL] [Abstract][Full Text] [Related]
15. Combined ethanol extract of Funtumia africana and Abutilon mauritianium leaves improves the lipid profile and kidney function indices of benign prostatic hyperplasia in rats.
Uroko RI; Chukwu CN; Egba SI; Adamude FA; Ajuzie JC
Acta Sci Pol Technol Aliment; 2020; 19(4):395-404. PubMed ID: 33179480
[TBL] [Abstract][Full Text] [Related]
16. Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy.
Dutkiewicz S
Mater Med Pol; 1995; 27(1):15-7. PubMed ID: 8569270
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
Habib FK; Mason MK; Smith PH; Stitch SR
Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
[TBL] [Abstract][Full Text] [Related]
18. Status and Interrelationship of Zinc, Copper, Iron, Calcium and Selenium in Prostate Cancer.
Singh BP; Dwivedi S; Dhakad U; Murthy RC; Choubey VK; Goel A; Sankhwar SN
Indian J Clin Biochem; 2016 Mar; 31(1):50-6. PubMed ID: 26855488
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
20. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
